AEMD Stock Analysis: Buy, Sell, or Hold?
AEMD - AETHLON MEDICAL INC
$3.21
2.54 (381.40%)
β²
5d:
+469.45%
30d:
+306.33%
90d:
+33.75%
WAIT
LOW Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 12, 2026
7d
Get Alerted When AEMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR BETTER ENTRY: AEMD is 234.4% above its trading range ($0.96). While momentum could continue, risk/reward favors waiting for a pullback.
βΈοΈ WAIT FOR BETTER ENTRY: AEMD is 234.4% above its trading range ($0.96). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: AEMD is currently trading at $3.21, which is considered slightly low relative to its 30-day fair value range of $0.53 to $0.96.
Technical Outlook: Technically, AEMD is in a strong downtrend. The price is approaching resistance at $0.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 381.4% recently.
Market Sentiment: AEMD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.25 (+387.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AEMD is in a strong downtrend. The price is approaching resistance at $0.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 381.4% recently.
Market Sentiment: AEMD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.25 (+387.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.53 -
$0.96
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+381.4%)
- BULLISH: Trading 387.4% below Wall St target ($3.25)
- WARNING: Recommendation downgraded due to 234.4% overvaluation
Trading Range Analysis
30-Day Trading Range
$0.53 -
$0.96
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.53
Resistance Level
$0.75
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.68
Wall Street Target
$3.25
(+387.4%)
Revenue Growth (YoY)
4278.2%
Share & Embed Analysis
Last updated: August 04, 2026 11:55 AM ET
Data refreshes hourly during market hours. Next update: 12:55 PM
Data refreshes hourly during market hours. Next update: 12:55 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AEMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 57 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 50 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 54 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 60 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 50 HOLD |